In-depth research guides covering peptides, compounds, and laboratory supplies. For research use only.
Research peptide regulations vary dramatically by country. This guide maps the regulatory landscape across the US, UK, EU, Australia, and Canada so researchers know what they are working within.
The peptide industry is about to change more in 12 months than it has in the last decade. Here’s what FDA reclassification means for quality, access, pricing, and the people who’ve been in this space all along.
Switching research protocols between peptide compounds requires careful planning. This guide covers washout periods, baseline documentation, and how to structure a clean transition.
The ‘Research Use Only’ label is not just fine print. This article explains what it means legally, what it does not mean, and what researchers need to know about buying and using RUO compounds.
14 of 19 restricted peptides are being reclassified in 2026. Here’s every peptide on the list, what each one is known for, the confirmed FDA timeline, and what Category 1 status actually means.
Having research peptides seized by customs is frustrating but not always final. Here is how to navigate the process, file a petition, and work with your vendor to resolve the situation.
NorthPeptide’s 2026 catalog brings new additions, restocked staples, and expanded support for GLP-1 and longevity research. Here is what researchers need to know.
RFK Jr announced 14 peptides moving out of Category 2 on Joe Rogan. The FDA advisory committee is now confirmed for July 2026. Here’s the full timeline, every peptide on the list, and what reclassification actually means.
Not all peptide vendors ship at the same speed or reliability. Here is exactly what to look for before you place an order.
Not all purity measurements are the same. HPLC, mass spectrometry, and amino acid analysis each reveal different things about a peptide — and understanding the differences helps you read a Certificate of Analysis correctly.
